Influence of clear cell carcinoma on the post-hepatectomy prognosis of patients with hepatocellular carcinoma

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Ferlay J, Soerjomataram I, Dikshit R et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136(5), e359–e386 (2015).
  Medline CASGoogle Scholar
• 2. Lai C, Wu P, Lam K, Todd D. Histologic prognostic indicators in hepatocellular carcinoma. Cancer 44(5), 1677–1683 (1979). •• First observational study reporting better long-term prognosis of primary clear cell carcinoma of the liver (PCCCL) compared with other histological types of hepatocellular carcinoma (HCC).
  Medline CASGoogle Scholar
• 3. Emile JF, Lemoine A, Azoulay D, Debuire B, Bismuth H, Reynes M. Histological, genomic and clinical heterogeneity of clear cell hepatocellular carcinoma. Histopathology 38(3), 225–231 (2001).
  Medline CASGoogle Scholar
• 4. Yang SH, Watanabe J, Nakashima O, Kojiro M. Clinicopathologic study on clear cell hepatocellular carcinoma. Pathol. Int. 46(7), 503–509 (1996).
  Medline CASGoogle Scholar
• 5. Buchanan TF Jr, Huvos AG. Clear-cell carcinoma of the liver: a clinicopathologic study of 13 patients. Am. J. Clin. Pathol. 61(4), 529–539 (1974).
  MedlineGoogle Scholar
• 6. Liu Z, Ma W, Li H, Li Q. Clinicopathological and prognostic features of primary clear cell carcinoma of the liver. Hepatol. Res. 38(3), 291–299 (2008). • Found that PCCCL showed superior prognosis compared with other histological types and revealed the associated risk factors of early and late intrahepatic recurrence.
  MedlineGoogle Scholar
• 7. Adamek HE, Spiethoff A, Kaufmann V, Jakobs R, Riemann JF. Primary clear cell carcinoma of noncirrhotic liver: immunohistochemical discrimination of hepatocellular and cholangiocellular origin. Dig. Dis. Sci. 43(1), 33 (1998).
  Medline CASGoogle Scholar
• 8. Ji S-P, Li Q, Dong H. Therapy and prognostic features of primary clear cell carcinoma of the liver. World J. Gastroenterol. 16(6), 764 (2010).
  MedlineGoogle Scholar
• 9. Edmondson HA. Tumors of the liver and intrahepatic bile ducts. In: Atlas of Tumor Pathology. Armed Forces Institute of Pathology, US (1958).
  Google Scholar
• 10. Li T, Fan J, Qin L-X et al. Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver. Ann. Surg. Oncol. 18(7), 1955–1963 (2011).
  Medline CASGoogle Scholar
• 11. Chen Z-S, Zhu S-L, Qi L-N, Li L-Q. Long-term survival and prognosis for primary clear cell carcinoma of the liver after hepatectomy. Onco Targets Ther. 9, 4129 (2016). •• Reports better long-term prognosis of PCCCL compared with other histological types of HCC.
  Medline CASGoogle Scholar
• 12. Mcdermott WV, Cady B, Georgi B, Steele G, Khettry U. Primary cancer of the liver: evaluation, treatment, and prognosis. Arch. Surg. 124(5), 552–555 (1989).
  Medline CASGoogle Scholar
• 13. Zhang Z, Xie H, Chen P, Cao P. Development and identification of a nomogram prognostic model for patients with primary clear cell carcinoma of the liver. Med. Sci. Monit. 26, e919789 (2020). • Develops and validates a nomogram to predict prognosis of PCCCL.
  Medline CASGoogle Scholar
• 14. Zhu S-L, Zhong J-H, Ke Y, Ma L, You X-M, Li L-Q. Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma. World J. Gastroenterol. 21(32), 9630 (2015).
  MedlineGoogle Scholar
• 15. Belghiti J, Noun R, Malafosse R et al. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann. Surg. 229(3), 369 (1999).
  Medline CASGoogle Scholar
• 16. Xia Y, Yan Z-L, Xi T et al. A case-control study of correlation between preoperative serum AFP and recurrence of hepatocellular carcinoma after curative hepatectomy. Hepatogastroenterology 59(119), 2248–2254 (2012).
  Medline CASGoogle Scholar
• 17. Luo Y, Ren F, Liu Y et al. Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis. Int. J. Clin. Exp. Med. 8(7), 10235 (2015).
  MedlineGoogle Scholar
• 18. Park SK, Jung YK, Chung DH et al. Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience. Korean J. Intern. Med. 28(4), 428 (2013).
  Medline CASGoogle Scholar
• 19. Wada H, Eguchi H, Nagano H et al. Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis. Surg. Today 48(1), 73–79 (2018).
  MedlineGoogle Scholar
• 20. Zhou L, Rui J-A, Wang S-B et al. Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy. World J. Surg. 31(9), 1782–1787 (2007).
  MedlineGoogle Scholar
• 21. Shi C, Zhao Q, Liao B et al. Anatomic resection and wide resection margin play an important role in hepatectomy for hepatocellular carcinoma with peritumoural micrometastasis. ANZ J. Surg. 89(11), e482–e486 (2019).
  MedlineGoogle Scholar
• 22. Zhang X, Li J, Shen F, Lau WY. Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 33(2), 347–354 (2018).
  MedlineGoogle Scholar
• 23. Liu Q-Y, Li H-G, Gao M, Lin X-F, Li Y, Chen J-Y. Primary clear cell carcinoma in the liver: CT and MRI findings. World J. Gastroenterol. 17(7), 946 (2011).
  MedlineGoogle Scholar
• 24. Steffens S, Janssen M, Roos FC et al. Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma–a multicentre study. Eur. J. Cancer 48(15), 2347–2352 (2012).
  MedlineGoogle Scholar
• 25. Sugiyama T, Kamura T, Kigawa J et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 88(11), 2584–2589 (2000).
  Medline CASGoogle Scholar
• 26. Chen M-F, Hwang T-L, Jeng L-B, Wang C-S, Jan Y-Y, Chen S-C. Postoperative recurrence of hepatocellular carcinoma: two hundred five consecutive patients who underwent hepatic resection in 15 years. Arch. Surg. 129(7), 738–742 (1994).
  Medline CASGoogle Scholar
• 27. Fuster J, García-Valdecasas JC, Grande L et al. Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann. Surg. 223(3), 297 (1996).
  Medline CASGoogle Scholar
• 28. Poon RTP, Fan ST, Ng IOL, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89(3), 500–507 (2000).
  Medline CASGoogle Scholar
• 29. Dai X, Xue J, Hu J et al. Positive expression of programmed death ligand 1 in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. Transl. Oncol. 10(4), 511–517 (2017).
  MedlineGoogle Scholar
• 30. Dai T, Peng L, Lin G et al. Preoperative elevated plasma fibrinogen level predicts tumor recurrence and poor prognosis in patients with hepatocellular carcinoma. J. Gastrointest. Oncol. 10(6), 1049 (2019).
  MedlineGoogle Scholar
• 31. Zhong F-P, Zhang Y-J, Liu Y, Zou S-B. Prognostic impact of surgical margin in patients with hepatocellular carcinoma: a meta-analysis. Medicine (Baltimore) 96(37), e8043 (2017).
  MedlineGoogle Scholar